deficiency beta-arrestin- signal complex contributes insulin resistance 
insulin resistance hallmark type diabetes defect insulin stimulating insulin receptor signalling12 become one serious public health threats upon stimulation insulin insulin receptor recruits phosphorylates insulin receptor substrate proteins3 leading activation phosphatidylinositol--oh kinase pi3 k-akt pathway activated akt phosphorylates downstream kinases transcription factors thus mediating metabolic actions insulin4- beta-arrestins mediate biological functions g-protein-coupled receptors linking activated receptors distinct sets accessory effecter proteins thereby determining specificity efficiency capacity signals7- show diabetic mouse models beta-arrestin- severely downregulated knockdown beta-arrestin- exacerbates insulin resistance whereas administration beta-arrestin- restores insulin sensitivity mice investigation reveals insulin stimulates formation new beta-arrestin- signal complex beta-arrestin- scaffolds akt src insulin receptor loss dysfunction beta-arrestin- results deficiency signal complex disturbance insulin signalling vivo thereby contributing development insulin resistance progression type diabetes findings provide new insight molecular pathogenesis insulin resistance implicate new preventive therapeutic strategies insulin resistance type diabetes 
